Stephen Brady is the founder of Millendo Therapeutics. Millendo Therapeutics has raised $118M in total funding. Latest round: Series B. Backed by NEA, Roche.
Stephen Brady is a veteran CEO who has been appointed to lead Claris Bio. Claris Bio is an eye drug biotech that is developing what it hopes to be the first drug therapy for limbal stem cell deficiency, a blinding condition. The company recently raised $118 million in a Series B round.
Full founder directory · Investor directory · Company funding database · Fundraising library